Last quarter (Q ), OncoVista Innovative Therapies's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q, OncoVista Innovative Therapies's net income was $-326.10K. See OncoVista Innovative Therapies’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 14	Dec 13	Dec 12	Dec 11	Dec 10
Total Revenue	-	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Cost of Revenue	-	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	-	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Operating Expense	$ 3.40M	$ 2.55M	$ 1.52M	$ 1.98M	$ 2.20M	$ 2.40M
Operating Income	$ -3.40M	$ -2.55M	$ -1.52M	$ -1.98M	$ -2.20M	$ -2.40M
Net Non Operating Interest Income Expense	$ -25.03K	$ -8.32K	$ 109.00	$ -3.48K	$ -17.05K	$ -147.01K
Other Income Expense	$ 159.07K	$ 9.73K	$ 72.47K	$ 356.01K	$ -11.40K	$ 255.59K
Pretax Income	$ -3.27M	$ -2.54M	$ -1.45M	$ -1.63M	$ -2.23M	-
Tax Provision	-	-	-	-	-	-
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -3.27M	$ -2.54M	$ -1.45M	$ -1.63M	$ -2.03M	$ 10.10M
Basic EPS	$ -0.14	$ -0.12	$ -0.07	$ -0.08	$ -0.10	$ 0.50
Diluted EPS	$ -0.14	$ -0.12	$ -0.07	$ -0.08	$ -0.10	$ 0.50
Basic Average Shares	$ 88.80M	$ 21.65M	$ 21.63M	$ 21.51M	$ 21.31M	$ 20.48M
Diluted Average Shares	$ 88.80M	$ 21.65M	$ 21.63M	$ 21.51M	$ 21.31M	$ 20.48M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 3.40M	$ 2.55M	$ 1.52M	$ 1.98M	$ 2.20M	$ 2.40M
Net Income From Continuing And Discontinued Operation	$ -3.27M	$ -2.54M	$ -1.45M	$ -1.63M	$ -2.03M	$ 10.10M
Normalized Income	$ -3.43M	$ -2.55M	$ -1.52M	$ -1.98M	$ -2.22M	$ -2.36M
Interest Expense	$ 20.97K	-	$ 152.00	$ 6.85K	$ 24.07K	$ 147.01K
EBIT	$ -3.26M	$ -2.55M	$ -1.52M	$ -1.62M	$ -2.21M	$ -2.40M
EBITDA	$ -3.26M	$ -2.55M	$ -1.52M	$ -1.62M	$ -2.20M	$ -2.39M

Currency in USD

OncoVista Innovative Therapies Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing